Shane Barton - Feb 18, 2025 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Principal Accounting Officer
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Stock symbol
BIOA
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
4
Date filed
2/20/2025, 04:15 PM
Previous filing
Dec 20, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +90K $0.00 90K Feb 18, 2025 Common Stock 90K $4.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.